We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$46.8B
AUM Growth
+$933M
Cap. Flow
+$2.08B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
452

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$255M
2
PGR icon
Progressive
PGR
+$244M
3
V icon
Visa
V
+$238M
4
LRCX icon
Lam Research
LRCX
+$201M
5
ELV icon
Elevance Health
ELV
+$190M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Healthcare 13.28%
3 Financials 10.32%
4 Industrials 9.79%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOL
3401
DELISTED
Emeren Group
SOL
-11,900
Closed -$24.2K
SONN
3402
DELISTED
Sonnet BioTherapeutics
SONN
-19,203
Closed -$28K
SPYX icon
3403
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.84B
-88,900
Closed -$4.28M
SSTK icon
3404
Shutterstock
SSTK
$197M
-125,441
Closed -$3.81M
SSYS icon
3405
Stratasys
SSYS
$692M
-29,325
Closed -$261K
STHO icon
3406
Star Holdings Shares of Beneficial Interest
STHO
$118M
-18,129
Closed -$176K
STKL
3407
DELISTED
SunOpta
STKL
-56,428
Closed -$434K
STOK icon
3408
Stoke Therapeutics
STOK
$2.08B
-53,950
Closed -$595K
STXF
3409
Strive 500 ETF
STXF
$1.17B
-95,000
Closed -$3.59M
SYRE icon
3410
Spyre Therapeutics
SYRE
$9.39B
-9,638
Closed -$224K
TALO icon
3411
Talos Energy
TALO
$2.92B
-101,874
Closed -$989K
TCBI icon
3412
Texas Capital Bancshares
TCBI
$4.27B
-89,608
Closed -$7.01M
TDG icon
3413
TransDigm Group
TDG
$66.4B
-1,850
Closed -$2.34M
TENX icon
3414
Tenax Therapeutics
TENX
$65.5M
-13,521
Closed -$83.7K
TGT icon
3415
Target
TGT
$75.1B
-35,534
Closed -$4.8M
THR
3416
DELISTED
Thermon Group Holdings
THR
-7,835
Closed -$225K
VBIO
3417
Valion Bio
VBIO
$509K
-715
Closed -$4.21K
TKNO icon
3418
Alpha Teknova
TKNO
$395M
-15,148
Closed -$126K
TLS icon
3419
Telos
TLS
$336M
-70,376
Closed -$241K
TMFC icon
3420
Motley Fool 100 Index ETF
TMFC
$2.08B
-126,900
Closed -$7.63M
TNK icon
3421
Teekay Tankers
TNK
$3.16B
-63,900
Closed -$2.54M
TNL icon
3422
Travel + Leisure Co
TNL
$4.39B
-21,306
Closed -$1.07M
TNXP icon
3423
Tonix Pharmaceuticals
TNXP
$215M
-2,008
Closed -$66.2K
TOL icon
3424
Toll Brothers
TOL
$13.7B
-8,798
Closed -$1.11M
TOUR
3425
Tuniu
TOUR
$53.2M
-10,881
Closed -$111K

Similar funds

John Overdeck's Q1 2025 Portfolio in Review

As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.

  • John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
  • John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
  • John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
  • John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
  • John Overdeck opened 458 new positions and closed 452 in Q1 2025.
  • John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.